These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 15837249)
21. Volumetric intravascular ultrasound analysis of Paclitaxel-eluting and bare metal stents in acute myocardial infarction: the harmonizing outcomes with revascularization and stents in acute myocardial infarction intravascular ultrasound substudy. Maehara A; Mintz GS; Lansky AJ; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA; Parise H; Mehran R; Stone GW Circulation; 2009 Nov; 120(19):1875-82. PubMed ID: 19858413 [TBL] [Abstract][Full Text] [Related]
22. The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES). Serruys PW; Sianos G; Abizaid A; Aoki J; den Heijer P; Bonnier H; Smits P; McClean D; Verheye S; Belardi J; Condado J; Pieper M; Gambone L; Bressers M; Symons J; Sousa E; Litvack F J Am Coll Cardiol; 2005 Jul; 46(2):253-60. PubMed ID: 16022951 [TBL] [Abstract][Full Text] [Related]
23. Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial). Nikolsky E; Kosinski E; Mishkel GJ; Kimmelstiel C; McGarry TF; Mehran R; Leon MB; Russell ME; Ellis SG; Stone GW Am J Cardiol; 2005 Mar; 95(6):709-15. PubMed ID: 15757595 [TBL] [Abstract][Full Text] [Related]
24. An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents. Liu J; Maehara A; Mintz GS; Weissman NJ; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Stone GW Am J Cardiol; 2009 Feb; 103(4):501-6. PubMed ID: 19195510 [TBL] [Abstract][Full Text] [Related]
25. Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents. Mintz GS; Hong MK; Raizner AE; Lee CW; Kim JJ; Escolar E; Fearnot NE; Park SW; Park SJ; Weissman NJ Am J Cardiol; 2005 Jan; 95(1):107-9. PubMed ID: 15619404 [TBL] [Abstract][Full Text] [Related]
26. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial. Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Costa MA; Alfonso F; Gómez-Hospital JA; Hernández-Antolín R; Bañuelos C; Goicolea J; Fernández-Avilés F; Bass T; Escaned J; Moreno R; Fernández C; Macaya C; J Am Coll Cardiol; 2006 Jun; 47(11):2172-9. PubMed ID: 16750681 [TBL] [Abstract][Full Text] [Related]
27. Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome study. Futamatsu H; Sabaté M; Angiolillo DJ; Jimenez-Quevedo P; Corros C; Morikawa-Futamatsu K; Alfonso F; Jiang J; Cervinka P; Hernandez-Antolin R; Macaya C; Bass TA; Costa MA J Am Coll Cardiol; 2006 Sep; 48(6):1139-45. PubMed ID: 16978996 [TBL] [Abstract][Full Text] [Related]
28. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Grube E; Silber S; Hauptmann KE; Mueller R; Buellesfeld L; Gerckens U; Russell ME Circulation; 2003 Jan; 107(1):38-42. PubMed ID: 12515740 [TBL] [Abstract][Full Text] [Related]
29. Toxic vessel reaction to an absorbable polymer-based paclitaxel-eluting stent in pig coronary arteries. Jabara R; Chronos N; Tondato F; Conway D; Molema W; Park K; Mabin T; King S; Robinson K J Invasive Cardiol; 2006 Aug; 18(8):383-90. PubMed ID: 16877788 [TBL] [Abstract][Full Text] [Related]
30. Paclitaxel-eluting stents: current clinical experience. Grube E; Buellesfeld L Am J Cardiovasc Drugs; 2004; 4(6):355-60. PubMed ID: 15554720 [TBL] [Abstract][Full Text] [Related]
31. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Tanabe K; Serruys PW; Degertekin M; Grube E; Guagliumi G; Urbaszek W; Bonnier J; Lablanche JM; Siminiak T; Nordrehaug J; Figulla H; Drzewiecki J; Banning A; Hauptmann K; Dudek D; Bruining N; Hamers R; Hoye A; Ligthart JM; Disco C; Koglin J; Russell ME; Colombo A; Circulation; 2005 Feb; 111(7):900-5. PubMed ID: 15710761 [TBL] [Abstract][Full Text] [Related]
32. Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late "catch-up" phenomenon from ASPECT Study. Park DW; Hong MK; Mintz GS; Lee CW; Song JM; Han KH; Kang DH; Cheong SS; Song JK; Kim JJ; Weissman NJ; Park SW; Park SJ J Am Coll Cardiol; 2006 Dec; 48(12):2432-9. PubMed ID: 17174179 [TBL] [Abstract][Full Text] [Related]
33. Revisiting late loss and neointimal volumetric measurements in a drug-eluting stent trial: analysis from the SPIRIT FIRST trial. Tsuchida K; García-García HM; Ong AT; Valgimigli M; Aoki J; Rademaker TA; Morel MA; van Es GA; Bruining N; Serruys PW Catheter Cardiovasc Interv; 2006 Feb; 67(2):188-97. PubMed ID: 16400664 [TBL] [Abstract][Full Text] [Related]
34. The paclitaxel (TAXUS)-eluting stent: a review of its use in the management of de novo coronary artery lesions. Waugh J; Wagstaff AJ Am J Cardiovasc Drugs; 2004; 4(4):257-68. PubMed ID: 15285700 [TBL] [Abstract][Full Text] [Related]
35. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Stone GW; Ellis SG; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Popma JJ; Russell ME; Circulation; 2004 Apr; 109(16):1942-7. PubMed ID: 15078803 [TBL] [Abstract][Full Text] [Related]
36. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME; JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618 [TBL] [Abstract][Full Text] [Related]
37. Comparison of quantitative angiographic parameters with the magnitude of neointimal hyperplasia measured by volumetric intravascular ultrasound in patients treated with bare metal and nonpolymeric paclitaxel-coated stents. Mintz GS; Hong MK; Raizner AE; Lee CW; Kim JJ; Escolar E; Fearnot NE; Park SW; Park SJ; Weissman NJ Am J Cardiol; 2005 Jan; 95(1):105-7. PubMed ID: 15619403 [TBL] [Abstract][Full Text] [Related]
38. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Colombo A; Drzewiecki J; Banning A; Grube E; Hauptmann K; Silber S; Dudek D; Fort S; Schiele F; Zmudka K; Guagliumi G; Russell ME; Circulation; 2003 Aug; 108(7):788-94. PubMed ID: 12900339 [TBL] [Abstract][Full Text] [Related]
39. Impact of preinterventional arterial remodeling on neointimal hyperplasia after implantation of (non-polymer-encapsulated) paclitaxel-coated stents: a serial volumetric intravascular ultrasound analysis from the ASian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Mintz GS; Tinana A; Hong MK; Lee CW; Kim JJ; Fearnot NE; Park SW; Park SJ; Weissman NJ Circulation; 2003 Sep; 108(11):1295-8. PubMed ID: 12952833 [TBL] [Abstract][Full Text] [Related]
40. A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions. Carrié D; Berland J; Verheye S; Hauptmann KE; Vrolix M; Violini R; Dibie A; Berti S; Maupas E; Antoniucci D; Schofer J J Am Coll Cardiol; 2012 Apr; 59(15):1371-6. PubMed ID: 22284328 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]